Monthly Archives: March 2021

Update from the PQRI PODP Working Group

The PQRI Parenteral and Ophthalmic Drug Product Leachables and Extractables (PODP L&E) Working Group has posted a brief update on their work to develop a risked–based approach for evaluation and safety qualification of leachables in PODPs, and Dr. Mary Richardson, iuvo’s Chief Scientific Officer, is a member of the PQRI Working Group.  The update is […]

What to look for in a preclinical consultant: Insights from Dr. Mary Richardson and Dr. Kathleen Krenzer

When developing a new pharmaceutical product, it is important to assemble the right team with the right expertise to enable an effective development program with the highest probability of success.  For startup companies who are focused on one or two assets, it frequently is not possible to hire all the individual specialties required to develop […]